The Board of Directors of Vimian Group AB has based on the authorisation from the Annual General Meeting on 2 June 2023, resolved on a rights issue of up to approximately SEK 1,633 million.

The purpose of the Rights Issue is to be able to act on value-accretive acquisition opportunities in the near term by strengthening the Company’s financial position. Along with the Rights Issue, Vimian’s Board of Directors has adopted new financial targets for the Company and declares its intention to change listing venue to Nasdaq Stockholm main market within the next twelve months.

As Vimian’s largest stakeholder Fidelio Vet Holding AB (“Fidelio”), has undertaken to subscribe for new shares in the Company corresponding to our respective pro rata share of the Rights Issue. In addition to its subscription commitment, Fidelio has entered into a guarantee commitment regarding subscription for additional shares, corresponding to approximately 26 percent of the Rights Issue.